LEXINGTON, Mass., Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- Keros Therapeutics, Inc. ( &#34;Keros&#34; or the &#34;Company&#34; ) ( Nasdaq: KROS ) , today announced the preliminary results of its cash tender offer ( the &#34;Tender Offer&#34; ) to repurchase up to 10,950,165 shares of its common stock, at a fixed purchase ...

KROS

<p>马萨诸塞州列克星敦，2025 年 11 月 19 日（GLOBE NEWSWIRE）-- Keros Therapeutics, Inc.（“Keros” 或 “公司”）（纳斯达克：KROS）今天宣布了其现金收购要约（“收购要约”）的初步结果，计划回购最多 10,950,165 股普通股，按固定价格</p>

Keros Therapeutics 宣布要约收购的初步结果